(Q42255061)

19 October 2017

title

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage (English)

1 reference

19 October 2017

9

Muhamed-Kheir Taha

1 reference

19 October 2017

Valérie Delbos

1

1 reference

19 October 2017

Ludovic Lemée

2

1 reference

19 October 2017

Jacques Bénichou

3

1 reference

19 October 2017

Gilles Berthelot

4

1 reference

19 October 2017

Ala-Eddine Deghmane

5

1 reference

19 October 2017

Jean-Philippe Leroy

6

1 reference

19 October 2017

Estelle Houivet

7

1 reference

19 October 2017

Eva Hong

8

1 reference

19 October 2017

François Caron

10

1 reference

19 October 2017

B14 STOP study group

11

1 reference

19 October 2017

language of work or name

English

0 references

publication date

12 July 2013

1 reference

19 October 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 October 2017

volume

31

1 reference

19 October 2017

issue

40

1 reference

19 October 2017

page(s)

4416-4420

1 reference

The changing and dynamic epidemiology of meningococcal disease

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Bexsero: a multicomponent vaccine for prevention of meningococcal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Lessons from meningococcal carriage studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Meningococcal carriage during a clonal meningococcal B outbreak in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Detection and genotyping of meningococci using a nested PCR approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Molecular typing of meningococci: recommendations for target choice and nomenclature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

"Herd immunity" and the meningococcal vaccine trial in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.080

10.1016/J.VACCINE.2013.06.080

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference